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Abstract
 
The recently described tumor necrosis factor (TNF) family member LIGHT (herpes virus en-
try mediator [HVEM]-L/TNFSF14), a ligand for the lymphotoxin (LT)
 
 
 
 receptor, HVEM,
and DcR3, was inactivated in the mouse. In contrast to mice deficient in any other member
of the LT core family, LIGHT
 
 
 
/
 
 
 
 mice develop intact lymphoid organs. Interestingly, a lower
percentage of LIGHT
 
 
 
/
 
 
 
LT
 
 
 
 
 
/
 
 
 
 animals contain mesenteric lymph nodes as compared with
LT
 
 
 
 
 
/
 
 
 
 mice, whereas the splenic microarchitecture of LIGHT
 
 
 
/
 
 
 
LT
 
 
 
 
 
/
 
 
 
 and LT
 
 
 
 
 
/
 
 
 
 mice
shows a comparable state of disruption. This suggests the existance of an additional undiscov-
ered ligand for the LT
 
 
 
 receptor (LT
 
 
 
R)
 
 
 
or a weak LT
 
 
 
3
 
–LT
 
 
 
R interaction in vivo in-
volved in the formation of secondary lymphoid organs. LIGHT acts synergistically with
CD28 in skin allograft rejection in vivo. The underlying mechanism was identified in in vitro
allogeneic MLR studies, showing a reduced cytotoxic T lymphocyte activity and cytokine
production. Detailed analyses revealed that proliferative responses specifically of CD8
 
 
 
 T cells
are impaired and interleukin 2 secretion of CD4
 
 
 
 T cells is defective in the absence of
LIGHT. Furthermore, a reduced 
 
3
 
[H]-thymidine incorporation after T cell receptor stimula-
tion was observed. This for the first time provides in vivo evidence for a cooperative role for
LIGHT and LT
 
 
 
 in lymphoid organogenesis and indicates important costimulatory functions
for LIGHT in T cell activation.
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Introduction
 
Members of the TNF superfamily are involved in a broad
range of biological functions such as cell proliferation and
differentiation, apoptosis, and lymphoid organogenesis (1–
3). TNF, lymphotoxin (LT)
 
*
 
 
 
, and LT
 
 
 
 together with the
recently identified TNF ligand family member LIGHT (4)
can be defined as a core group within the larger TNF su-
perfamily. The counterpart to the core family of ligands is
formed by four TNF receptor (TNFR) superfamily mem-
bers: TNFRp55; TNFRp75; LT
 
 
 
 receptor (LT
 
 
 
R); and
the herpes virus entry mediator (HVEM), that share over-
lapping but distinct ligand-binding patterns. TNF
 
3
 
 and
LT
 
 
 
3
 
 engage the TNFRp55 and TNFRp75 as homotri-
mers. In combination with the exclusively membrane
bound LT
 
 
 
, LT
 
 
 
 binds to the LT
 
 
 
R predominantly as
LT
 
 
 
1
 
 
 
2
 
 heterotrimer (5, 6).
LIGHT (HVEM-L, TNFSF14) is expressed as a homo-
trimer on activated T cells (4, 7) and also on immature
dendritic cells (DCs; reference 8). Three receptors with
distinct cellular expression patterns are described to inter-
act with LIGHT. LT
 
 
 
R, found on follicular DCs (FDCs)
and stromal cells (9, 10) binds LIGHT and LT
 
 
 
1
 
 
 
2
 
.
HVEM, in contrast, is detected on immature DCs (11,
12), T and B lymphocytes, NK cells, monocytes, and en-
dothelial cells (7, 13, 14) and signals upon engagement of
LIGHT or LT
 
 
 
3
 
. DcR3 (TR6), a TNFR family member
lacking a transmembrane region competes with LT
 
 
 
R and
HVEM for LIGHT engagement, thereby acting as a nega-
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Phenotype of LIGHT-deficient Mice
 
tive regulator. In addition to LIGHT, DcR3 also binds to
FasL (15, 16).
Overlapping but also nonredundant biological functions
have been assigned to ligands and receptors of the LT/TNF
core family using gene targeting techniques and treatment
with receptor fusion proteins or agonistic antibodies (17–
19). TNF, TNFRp55, and TNFRp75 are dispensable for
LNs formation, though TNF- and TNFRp55-deficient
mice fail to form germinal centers (GCs) and fully devel-
oped Peyer’s Patches (PP) (20–23). A more severe pheno-
type is observed in the absence of LT
 
 
 
1
 
 
 
2
 
-LT
 
 
 
R signaling
leading to a lack of all LNs, defects in T and B cell segrega-
tion, and FDC networks formation within the spleen (24).
This phenotype is largely shared by LT
 
 
 
-deficient mice
(25, 26), despite the fact that occasional lymphoid aggre-
gates appear in the mesentery of these animals (25). In con-
trast, mice deficient for LT
 
 
 
 retain mesenteric LNs
(MLNs) and in some cases cervical LNs (27, 28). Further-
more, the splenic microarchitecture in these animals ap-
pears less severely disturbed as compared with LT
 
 
 
 
 
/
 
 
 
 or
LT
 
 
 
R
 
 
 
/
 
 
 
 mice. In the search for an explanation for the
nonoverlapping phenotypes of mice deficient for LT
 
 
 
,
LT
 
 
 
, or LT
 
 
 
R it was speculated on the involvement of
LIGHT–LT
 
 
 
R or LIGHT–HVEM interactions during
lymphoid organogenesis.
So far, in vitro studies suggested a role of LIGHT as a
costimulatory molecule providing T cells with the “second
signal” in addition to “signal one” delivered by the T cell
receptor. For some other members of the TNF superfamily
such costimulatory functions in T cell activation have been
established (29). LIGHT induces T cell proliferation, NF-
 
 
 
B translocation, and secretion of IFN-
 
 
 
 in vitro (8, 30).
In vivo blockade of LIGHT and LT
 
 
 
1
 
 
 
2
 
 by administration
of LT
 
 
 
R-Fc leads to reduced T cell responses in a graft-
versus-host disease model (30). Recent studies demonstrate
that LIGHT cooperates with CD40 ligand in DC matura-
tion presumably by signaling via HVEM expressed on im-
mature DCs (12).
Here we report the generation and characterization of
LIGHT-deficient mice. Functional analysis of the pheno-
type of LIGHT
 
 
 
/
 
 
 
 mice indicates an essential costimula-
tory role for LIGHT in supporting T cell activation. With
respect to lymphoid organogenesis, LIGHT cooperates
with LT
 
 
 
 in formation of MLNs as demonstrated by the
comparison of LT
 
 
 
 singly deficient with LIGHT/LT
 
 
 
doubly deficient mice.
 
Materials and Methods
 
Cells.
 
E14.1 embryonic stem (ES) cells from 129/Ola mice
were grown in DMEM medium (GIBCO BRL) supplemented
with 
 
L
 
-glutamine (2 mM; Seromed), leukemia inhibitory factor,
penicillin/streptomycin (100 
 
 
 
g/ml; Seromed), 2-mercaptoetha-
nol (0.05 mM; GIBCO BRL), and 15% heat-inactivated FCS
(Boehringer).
P815 (H-2
 
d
 
) mouse mastocytoma and EL-4 (H-2
 
b
 
) mouse T
cell lymphoma cell lines were purchased from the American Type
Culture Collection (Rockville) and maintained in complete
 
RPMI 1640 medium (Biochrom) supplemented with 10% heat-
inactivated FCS (Boehringer), 0.05 mM 2-ME, and penicillin/
streptomycin (100 
 
 
 
g/ml; Seromed).
Mouse splenocytes were cultured in RPMI 1640 medium
(Biochrom) supplemented with 5% heat-inactivated FCS (Boeh-
ringer), 0.05 mM 2-ME, Hepes-Buffer (10 mM; GIBCO BRL),
and Pen/Strep (100 
 
 
 
g/ml; Seromed).
 
Targeting the LIGHT Genomic Locus by Homologous Recombina-
tion.
 
A murine genomic ES-129 BAC library (Genome Sys-
tems Inc.) was screened by hybridization with a 314-bp murine
 
light
 
 cDNA fragment as a probe. The resulting BAC clone was
mapped by Southern blot hybridization using murine 
 
light
 
cDNA fragments. Two adjacent BAC fragments of 4.0 kb and
5.8 kb containing the complete coding sequence for the 
 
light
 
 lo-
cus were cloned into pBluescript (Stratagene) and fully se-
quenced. The targeting vector was constructed in pBluescript in
a way that a 4.5-kb fragment of the genomic 
 
light
 
 locus encoding
the complete ORF of the LIGHT protein was replaced by a
neomycin resistance cassette, and a herpes simplex virus thymi-
dine kinase (HSV-TK) cassette was inserted 2.8 kb upstream of
the targeted sequence (Fig. 1 A). The neomycin resistance cas-
sette was inserted in antisense to the transcriptional direction of
LIGHT. RT-PCR for CD27-L, the TNF superfamily member
shown to be located in the same human genomic region next to
 
light
 
 (31), revealed undisturbed transcriptional regulation in un-
treated and PMA/ionomycin stimulated LIGHT
 
 
 
/
 
 
 
 splenocytes
(data not shown). E14.1 ES cells were electroporated with the
linearized targeting vector as described previously (32). G418-
and gancyclovir-resistant ES cell colonies were picked. Homol-
ogous recombination was detected by PCR and subsequently
confirmed by genomic Southern blot hybridization with a 3
 
 
 
flanking probe (see Fig. 1 A) after digestion of ES cell DNA with
SpeI (see Fig. 1 B). Single integration of the targeting vector was
verified by probing the Southern blot with the neomycin resis-
tance cassette (data not shown). Correctly targeted ES cell clones
were injected into C57BL/6 blastocysts, which were transferred
into pseudopregnant foster mothers. Resulting chimeric mice
were backcrossed to C57BL/6 mice, and germline transmission
of the targeted allele was confirmed by Southern blot analysis
(see Fig. 1 B).
 
Generation and Screening of LIGHT
 
 
 
/
 
 
 
 (H-2
 
b
 
), LIGHT
 
 
 
/
 
 
 
 (H-
2
 
d
 
), LIGHT
 
 
 
/
 
 
 
CD28
 
 
 
/
 
 
 
, LIGHT
 
 
 
/
 
 
 
LT
 
 
 
 
 
/
 
 
 
, and LT
 
 
 
R
 
 
 
/
 
 
 
Mice.
 
The LIGHT mutation was moved into a C57BL/6 back-
ground by at least three successive backcrosses, initiated with
(C57BL/6 
 
 
 
 129/Ola) F1 LIGHT
 
 
 
/
 
 
 
 mice. The resulting het-
erozygotes were intercrossed to establish C57BL/6 LIGHT
 
 
 
/
 
 
 
(H-2
 
b
 
) mice. Genotyping for the LIGHT mutation was per-
formed by PCR with the following primers: 5
 
 
 
-ACG CAT GTG
TCC TGC GTG TGG-3  (mLIGHT type1); 5 -CGA CAG
ACA TGC CAG GAA TGG-3  (mLIGHT type2); and 5 -GAC
GTA AAC TCC TCT TCA GAC-3  (pneo1).
To obtain mice deficient for LIGHT on a H-2d background,
C57BL/6 LIGHT /  mice were backcrossed once with BALB/c
mice and resulting LIGHT /  mice were mated with each other.
Progeny was FACS® analyzed for the H-2d haplotype on both al-
leles (staining for H-2Dd and I-Ad) and typed for the LIGHT mu-
tation.
To obtain mice deficient for CD28 and LIGHT, homozygous
single knockout mice on the C57BL/6 background (at least four
times backcrossed) were bred, F1 littermates intercrossed, and
progeny was genotyped. Genotyping for the CD28 mutation (33)
was performed by PCR using the following primers: 5 -CCT
GAG TCC TGA TCT GTC AGA CT-3  (979–54); 5 -CTG1615 Scheu et al.
CTT GTG GTA GAT AGC AAC GA-3  (979–55); and 5 -
ATT CGC CAA TGA CAA GAC GCT GG-3  (HSV-TK).
For the generation of LIGHT/LT  doubly deficient mice ho-
mozygous single knockout mice (27) on the C57BL/6 back-
ground (at least two times backcrossed) were bred to LIGHT / 
mice and F1 littermates crossed to LT  /  mice to obtain
LIGHT / LT  /  mice. These were backcrossed to C57BL/6
mice and the resulting doubly heterozygous mice were interbred
to obtain LIGHT and LT  singly deficient and LIGHT/LT 
doubly deficient mice as littermates. Genotyping for the LT 
mutation was performed by PCR with the following primers: 5 -
CGG GTC TCC GAC CTA GAG ATC-3  (gtype1); 5 -CCA
CAA CAG GTG TGA CTG TCT C-3  (gtype2); and 5 -GAG
GTG GGT GGA TTG GAA AGA G-3  (gtype3).
LT R /  mice were at least six times backcrossed to the
C57BL/6 background, bred, and genotyped as described previ-
ously (24). Mice were kept according to German guidelines for
animal care in a SPF animal facility.
Northern Blot Analysis. Mouse splenocytes were stimulated
for 4 h with PMA (10 ng/ml) and Ca2 -Ionophor (200 ng/ml).
Total RNA was prepared, run on an 1% formamide gel, and blot-
ted on a Gene Screen membrane (Dupont). mRNAs for LIGHT
and TNF-  were detected using 32[P]-labeled cDNA probes con-
taining the whole ORF coding for the respective protein.
Analysis of MLN Formation. Mice were dissected and mesen-
teric regions were examined and documented using a Leica MZ
APO photomicroscope in combination with a JVC KY-F70 dig-
ital camera unit.
Histology. Tissue samples were embedded in tissue-freezing
medium (Leica) and snap-frozen in 2-methylbutane (Merck) pre-
chilled by liquid nitrogen. Cryostat sections (7  m) were fixed
for 8 min in acetone (Merck). Frozen sections were thawed, re-
hydrated, blocked, and incubated with biotinylated and FITC-
conjugated Abs in a dark humidified atmosphere for 1 h at RT.
After washing, PE-conjugated streptavidin (Becton Dickinson)
was added for 1 h; slides were washed and mounted with Fluoro-
mount-G (Southern Biotech). Analysis was performed 2–24 h
later with a laser scanning microscope (Zeiss).
Proliferation Assays. Lectin-induced T cell activation was per-
formed on total splenocytes (2.5   104 cells per well) cocultured
with titrated amounts of ConA (Sigma-Aldrich) in 96-well,
round-bottomed plates for 32 h. For TCR-mediated T cell acti-
vation total splenocytes (105 cells per well) or purified T cells
(4   105 cells per well) were stimulated with titrated amounts of
soluble or plate-bound monoclonal anti-CD3 Ab (BD PharMin-
gen), respectively, in 96-well round-bottomed plates for 72 h. T
cells were positively selected by Thy1.2-microbeads in a mag-
netic field according to the manufacturer’s instructions (Miltenyi
Biotec). The purity of isolated T cells was  95%. 3[H]-thymi-
dine incorporation of T cells was assessed by addition of 1  Ci
per well 3[H]-thymidine (Amersham Pharmacia Biotech) during
the last 6–9 h of the culture. Incorporation of 3[H]-thymidine
was measured with a Matrix™ 96 direct   counter (Packard In-
strument Co.). For cell cycle analysis, splenocytes were labeled
with 5  M CFSE (Molecular Probes) and stimulated with 2  g/
ml of soluble monoclonal anti-CD3 Ab (BD PharMingen) in 24-
well plates.
Vesicular Stomatitis Virus Infection. Vesicular stomatitis virus
(VSV) (Indiana serotype; Mudd-Summers isolate) was originally
obtained from D. Kolakofsky (University of Geneva, Geneva,
Switzerland), and was grown on BHK cells in MEM with 5%
FCS to virus stocks containing 109 PFU/ml. Mice were immu-
nized intravenously on day 0 with 2   106 PFU of VSV. For de-
termination of neutralizing Ab titers serial twofold dilutions of se-
rum samples (previously diluted 1:40) were mixed with equal
volumes of VSV containing 500 PFU/ml, and the mixtures were
incubated for 90 min at 37 C in an atmosphere containing 5%
CO2. 100  l of the mixture was transferred onto Vero cell
monolayers in 96-well plates and incubated for 1 h at 37 C.
Monolayers were overlaid with 100  l of DMEM containing 1%
methylcellulose, incubated for 24 h at 37 C, then the overlay was
removed and the monolayer was fixed and stained with 0.5%
crystal violet dissolved in 5% formaldehyde, 50% ethanol, and
4.25% NaCl. The dilution reducing the number of plaques by
50% was taken as titer. To determine IgG titers undiluted serum
was treated with an equal volume of 0.1 M 2-ME in MEM me-
dium for 1 h at RT (34). CTL activity against VSV was measured
using splenocytes on day 6 after infection in a standard 51[Cr]-
release assay on VSV-infected MC57 target cells.
Skin Grafting. Skin grafting was performed on anesthetized
recipients according to a technique of Davis et al. (35). Briefly, a
full thickness of tail skin (0.5 cm2) was grafted on the lateral flank.
Grafts were observed daily after removal of the bandage (day 8)
and considered rejected when no viable donor skin was pres-
ent. LIGHT /  CD28 / , LIGHT /  CD28 / , LIGHT / 
CD28 / , and LIGHT / CD28 /  littermate mice, were trans-
planted with allogeneic tailskin of LIGHT /  (H-2d) mice, to
exclude influences of LIGHT, possibly brought into the system
via the graft. Recipients were backcrossed at least four times into
the C57BL/6 background.
CTL Assay. 51[Cr]-release assays were performed with effec-
tor cells from allogeneic MLRs on day 5. EL-4 or P815 target
cells (106) were labeled with 100  Ci Na2
51CrO4 (Amersham
Pharmacia Biotech) for 1 h at 37 C and washed. 100  l (103 cells)
of these target cells were added to the same volume of replicate
serial dilutions of effector CTLs as indicated. After 4 h of incuba-
tion at 37 C, 100  l of culture supernatant were removed and ra-
dioactivity was measured. Specific lysis was calculated according
to the formula: percentage of specific lysis   (cpm [sample]  
cpm [spontaneous release])/(cpm [maximal release]   cpm
[spontaneous release])   100. Spontaneous release was 4–10%.
Allogeneic MLR and Measurement of Proliferative Responses and
Cytokines in the Supernatant. For induction of MLR, allogeneic
splenocytes (H-2b versus H-2d) were cocultured at concentrations
of 2   106 cells/ml for stimulator cells and total splenocytes as re-
sponders, 1.5   106 cells/ml for CD4-depleted responders, or
1.7   106 cells/ml for CD8-depleted responders. Depletion was
performed using anti-CD4 or anti-CD8 microbeads, respectively,
according to the manufacturer’s instructions (Miltenyi Biotec).
Depletion efficiency was  99%. The stimulator population was
irradiated with 30Gy. Proliferation was measured after 72 h of
MLR activation by addition of 1  Ci/well 3[H]-thymidine (Am-
ersham Pharmacia Biotech) during the last 9 h of the culture. After
5 d, culture supernatants were harvested and cytokine concentra-
tion was assessed by sandwich ELISA for IFN- , IL-2, IL-4,
IL-10, and IL-12p40 according to the manufacturer’s instructions
(R&D Systems). Detection limits are 2 pg/ml for IL-4 and IFN- ,
3 pg/ml for IL-2, and 4 pg/ml for IL-10 and IL-12p40.
Flow Cytometric Analysis. Aliquots of the allogeneic MLRs
were harvested on days 0, 4, and 5. After pretreatment with Fc-
block (anti-CD16/32; BD PharMingen), cells were stained for 10
min at 4 C with the indicated Abs. The following Abs were used
for staining of T lymphocytes: anti–CD4-bio (L3T4); anti–
CD8 -PE (Ly-2); anti–CD3 -Cy5 (145–2C11); and anti–
H-2Kb-FITC (KH95). Biotinylated Abs were detected using
streptavidin-PerCP (Becton Dickinson). Splenocytes were gated1616 Phenotype of LIGHT-deficient Mice
on CD3  H-2Kb lymphocytes for naive T cells on day 0 and on
CD3  H-2Kb high forward side scatter lymphocytes for MLR-
activated T cells on days 4 and 5. Fluorescence was analyzed us-
ing FACSCalibur™ flow cytometry and CELLQuest™ software
(both Becton Dickinson).
Results
Inactivation of the Murine LIGHT Gene. To evaluate the
functions of LIGHT in vivo, we generated LIGHT-defi-
cient mice by homologous recombination in ES cells. A
targeting vector was designed to replace the complete ge-
nomic region coding for the open reading frame by a neo-
mycin resistance cassette (Fig. 1 A). Two targeted mutant
ES cell clones were identified by Southern blot analysis and
injected into C57BL/6 blastocysts. The resulting chimeric
mice transmitted the disrupted light allele through the germ-
line. Homozygously mutant mice were identified by
Southern blot analysis of genomic tail DNA. SpeI bands of
5.8 and 2.6 kb were detected as the wild-type (WT) and
the mutated alleles, respectively (Fig. 1 B). LIGHT / 
mice were born healthy and proved fertile. Successful inac-
tivation of LIGHT was demonstrated by the absence of
LIGHT mRNA in PMA/Ionomycin activated splenocytes
as determined by Northern blot analysis (Fig. 1 C).
LIGHT /  mice derived from both ES cell clones showed
the same phenotype. Furthermore, in all assays performed
no significant differences between WT and LIGHT / 
mice were observed indicating that a single light allele is
sufficient for function.
Cooperation of LIGHT with LT  in MLN Formation.
Members of the TNF ligand and receptor superfamilies are
involved in lymphoid organogenesis. LT R-deficient mice
lack all peripheral and MLNs and PP and display a largely
destroyed splenic architecture (24). LT  /  mice which
are deficient for the LT 1 2-heterotrimeric ligand of the
LT R retain organized MLNs (27, 28). Furthermore, in
the spleen of LT  /  mice T and B cell compartmentaliza-
tion is largely intact. Because of this incomplete develop-
mental defect one can speculate on LIGHT, as a second
ligand for LT R, to be involved in the formation of sec-
ondary lymphoid tissues and their microarchitecture. Yet,
LIGHT /  mice develop a complete set of primary and
secondary lymphoid organs including peripheral and MLNs
and PP with unaltered microarchitecture (data not shown).
Flow cytometry analysis of primary and secondary lym-
phoid organs revealed normal cell counts for all major cell
populations (data not shown). In the spleen, all major cellu-
lar compartments, such as B cell follicles with FDCs and
GCs, T cell areas including DCs, and the marginal zones
are present and properly organized (data not shown). To
Figure 1. Generation of LIGHT /  mice. (A) The re-
striction map of the murine light genomic locus (top), the
targeting vector (middle), and the targeted allele (bottom)
are shown. Locations of translation start, stop codon, and
flanking probe are indicated. B, BamHI; K, KpnI; M, MfeI;
S, SpeI. (B) Southern blot hybridization of SpeI-digested
genomic DNA from targeted ES cell clones and mouse tail
biopsies with the 3  flanking probe yields a 5.8-kb fragment
for the WT allele and a 2.6-kb fragment for the targeted
allele. (C) The absence of LIGHT mRNA in mice ho-
mozygous for the targeted light allele is verified by North-
ern blot analysis. Total RNA was prepared from untreated
or PMA/ionomycin–activated splenocytes from LIGHT / ,
LIGHT / , and LIGHT /  mice and hybridized with
cDNA probes containing the whole ORF for murine
LIGHT or TNF-  (activation control). Methylene blue
staining of 28S and 18S rRNA serves as loading control.1617 Scheu et al.
verify functional integrity of secondary lymphoid organs
and intact GC function, high affinity Ab responses to T
cell–dependent (4-hydroxy-3-nitrophenyl-acetyl)-chicken
  globulin (NP-CG) immunization were assessed and
found unaltered in LIGHT /  mice with respect to IgM
and all IgG subclasses (data not shown). This demonstrates
functional class switch and affinity maturation and suggests
that sufficient LT R-signaling is accomplished by the pres-
ence of the LT 1 2 heterotrimer.
Mice deficient for LIGHT and LT  were intercrossed to
analyze lymphoid organogenesis in the absence of both
known ligands for the LT R. light and the lt -tnf -lt  lo-
cus are located on murine chromosome 17 (36). However,
the distance of  10 cM between the two loci allowed for
the breeding of LIGHT/LT  doubly deficient mice (un-
published data). No PP or brachial, axillary, inguinal,
popliteal, paraaortic, or parapancreatic LNs could be de-
tected in LIGHT / LT  /  mice and LIGHT / LT  / 
mice (data not shown). However, as compared with
LT  /  (27, 28) or LIGHT / LT  /  mice, there was a
marked reduction in the presence of MLNs (Fig. 2 A) in
LIGHT / LT  /  animals. Upon careful microscopic in-
spection, MLNs were found in all LIGHT / LT  / 
mice, whereas only in four out of 16 LIGHT / LT  / 
animals MLNs were present which was additionally veri-
fied by preparation of cryosections of the mesenteric re-
gions. The splenic microarchitecture of LIGHT / LT  / 
and LIGHT / LT  /  mice resembles that one de-
scribed for LT  /  mice (27, 28) with T cells accumulat-
ing around the central arteriole surrounded by a wall of B
cells. In contrast, T and B cell areas were completely inter-
mixed in LT R-deficient mice (24) (Fig. 2 B). In the
spleen and LNs of LIGHT / LT  /  mice no significant
differences compared with LIGHT / LT  /  mice were
observed in histological analysis.
Thus, it appears that, though LIGHT and LT  are able
to substitute for each other in morphogenesis of MLNs,
LT 3 (via HVEM?) or a yet undiscovered ligand for LT R
is responsible for the relatively conserved splenic T and B
cell segregation and the incomplete absence of MLNs in
LIGHT/LT  doubly deficient mice.
Proliferative Responses of LIGHT /  T Cells In Vitro.
Studies using exogenous addition/overexpression or, alter-
natively, blockade of LIGHT by receptor Fc-fusion pro-
teins have suggested LIGHT as a costimulatory molecule
which enhances T cell proliferation presumably through
HVEM (8, 30, 37). Total splenocytes or purified T cells
from LIGHT-deficient mice reproducibly showed reduced
amounts of 3[H]-thymidine incorporation induced by plate
bound or soluble anti-CD3 mAb, respectively, as com-
pared with those of WT or heterozygous littermate con-
trols (Fig. 3 B and C). This emphasizes the importance of
LIGHT as a costimulatory molecule in TCR-mediated T
cell responses, whereas its presence is not required to
achieve optimal proliferation in lectin-mediated T cell acti-
vation (Fig. 3 A). When cell cycle activity of TCR-stimu-
lated T lymphocytes was measured using the fluorescent
dye CFSE no differences between WT or LIGHT /  T
cells either of the CD4  or the CD8  subpopulations
could be detected (Fig. 3 D) rather suggesting a function of
LIGHT in supporting T cell survival.
VSV Infection in LIGHT-deficient Mice. To assess the
consequences of LIGHT deficiency for host resistance to
viral infections LIGHT /  and littermate control mice
were inoculated with 2   106 PFU VSV. After VSV infec-
tion, LIGHT /  mice and littermate controls mounted
similar neutralizing T cell–independent IgM responses
around day 4 after infection, followed by a T cell–depen-
dent switch to the IgG subclass between days 6 and 8 (38,
39) (Fig. 4 A). VSV-specific, ex vivo CTL activity showed
no significant differences between VSV-infected LIGHT / 
and LIGHT /  effector cells (Fig. 4 B). Similar results
were obtained when mice were infected with a lower dose
of 2   104 PFU VSV (data not shown). Thus, LIGHT does
not play a crucial role in the induction of a primary anti-
VSV immune response.
Figure 2. Reduced frequency of MLNs and relatively conserved
splenic architecture in LIGHT/LT  doubly deficient mice. (A) Analysis
of the mesenteric region of LIGHT / LT  / , LIGHT / LT  / ,
LIGHT / LT  / , and LIGHT / LT  /  animals. After dissection of
the abdominal wall the area of the mesenteric origin was prepared. MLNs
are indicated by arrows. Frequency of inguinal (ing) and MLNs in
LIGHT/LT  doubly deficient and LT  singly deficient littermates are
given. Five LIGHT / LT  /  mice and 16 LIGHT / LT  /  mice
were microscopically analyzed. (B) Confocal microscopy of spleen mi-
croarchitecture. Splenic sections from mice of the indicated genotype
were stained with fluorescence labeled anti-CD3 Abs (red) and anti-B220
Abs (green) to detect T and B cells, respectively.1618 Phenotype of LIGHT-deficient Mice
Skin Allograft Survival in LIGHT / CD28 /  Mice. To
address the role of LIGHT in antiallogeneic immune re-
sponses in vivo, allogeneic skin graft rejection was investi-
gated in LIGHT /  mice. A first set of experiments
showed, that LIGHT-deficient mice exhibited no signifi-
cant differences in their ability to acutely reject skin al-
lografts. The same was true for CD28 /  recipient mice as
described previously (40). Since CD28-mediated signals
work in synergy with some other TNF superfamily mem-
bers (e.g., 4–1BB, reference 41), LIGHT /  animals were
crossed to a CD28 /  background, to be able to assess the
importance of LIGHT as an alternative costimulatory mol-
ecule in the absence of a possibly complementing coacti-
vating pathway. In this setting, LIGHT / CD28 /  mice
showed a skin graft survival of up to 19 d, i.e., 6 d longer
than singly deficient or WT mice (Fig. 5). This indicates
Figure 3. T lymphocyte pro-
liferation in vitro in the absence
of LIGHT. (A) Normal prolifera-
tion of LIGHT /  T cells in re-
sponse to ConA stimulation.
Splenocytes from LIGHT-defi-
cient and WT mice were incu-
bated with titrated amounts of
ConA for 2 d. (B and C) Re-
duced  3[H]-thymidine incorpo-
ration of LIGHT /  splenocytes
upon TCR-mediated stimula-
tion. Purified T cells from
LIGHT /  and WT littermates
(B) or total splenocytes from
LIGHT / , LIGHT / , and
WT littermates (C) were cul-
tured for 72 h with the indicated
doses of plate-bound (B) or solu-
ble (C) anti-CD3 mAb. Cells
were pulsed with 1  Ci for the
last 6–9 h (B and C) or the last
4 h (A) of the culture. Shown is
one representative result of four
independent experiments, re-
spectively. (D) Unaltered cell cy-
cle activity of LIGHT-deficient
T lymphocytes. Splenocytes were
labeled with CFSE and incubated
with 2  g/ml soluble anti-CD3
mAb for 72 h. After that cells
were harvested and FACS® ana-
lyzed after gating on live CD4 
or CD8  cells, respectively.
Figure 4. Humoral and cel-
lular immune responses of
LIGHT /  mice to VSV infec-
tion. (A) Groups of three
LIGHT /  (white symbols) and
WT littermate control mice
(black symbols) were inocu-
lated with 2   106 PFU VSV
intravenously. Blood was taken
at the indicated time points.
Sera were separated and predi-
luted 40-fold, and neutralizing
VSV-specific total Ig (circles)
and IgG (triangles) responses
were analyzed. (B) Splenocytes
from LIGHT /  (black circles,
two mice) and LIGHT / 
(white circles, three mice) ani-
mals 6 d after infection with
2   106 PFU VSV were cocultured with 51[Cr]-labeled VSV-infected target cells and specific lysis was assessed. Control assays with unchallenged an-
imals or uninfected target cells showed no significant specific lysis (data not shown).1619 Scheu et al.
that LIGHT together with CD28 plays an important role
in allo-graft rejection.
MLR-induced CTL Activity and Cytokine Production in the
Absence of LIGHT. In search for the underlying cellular
mechanisms of the observed delay in skin graft rejection, it
was tested whether LIGHT is required for the generation
of efficient T cell effector functions in vitro, induced by an
allogeneic MLR. Possible influences of soluble LIGHT
shed from the cell surface by matrix metalloproteinases (7)
were excluded by comparing MLRs with LIGHT-defi-
cient effector as well as stimulator populations to those
with both populations heterozygous or WT for the light al-
lele. Interestingly, when tested for their ability to kill allo-
geneic target cells, LIGHT /  effector splenocytes showed
a marked reduction in specific target cell lysis as compared
with LIGHT /  effectors (Fig. 6 A). MLR supernatants
from LIGHT-deficient splenocytes contained remarkably
reduced amounts of IFN-  and IL-2, as well as IL-4 and
IL-10. In contrast, IL-12p40 concentrations, a cytokine
predominantly produced by DCs, were similar in all MLR
setups (Fig. 6 B). CD8/CD4 ratios of MLR-activated re-
sponder T cells were determined using FACS® analysis
(Fig. 6 C). On day 5, we found the ratio of CD8  versus
CD4  activated responder T cells significantly reduced by
40% in the LIGHT-deficient MLRs as compared with
those with LIGHT /  or WT splenocytes. The CD8/
CD4 ratio of naive splenocytes was comparable in WT,
LIGHT / , and LIGHT /  mice. To elucidate the differ-
ential effects of LIGHT on CD8  versus CD4  T cell sub-
populations, MLRs were performed after depletion of
CD4  T cells or CD8  T cells from the LIGHT /  or
LIGHT /  responder cells (Fig. 7). LIGHT /  CD4-
depleted MLRs showed drastically reduced proliferation as
compared with the corresponding LIGHT /  MLRs,
whereas in MLRs with CD8-depleted responder popu-
lations no significant differences in proliferation could
be found (Fig. 7 A). Supernatants from CD8-depleted
LIGHT /  MLRs showed drastically reduced amounts of
IL-2 as compared with LIGHT /  MLRs, clearly indicat-
ing LIGHT as a crucial cytokine for the induction of IL-2
secretion by CD4  T cells. In accordance with published
results, only very small amounts of IL-2 could be measured
after CD4-depletion independent of LIGHT expression
(Fig. 7 B). Concentrations of IFN-  and IL-4 in superna-
tants from MLRs with CD4- or CD8-depleted T cell sub-
populations were below the detection limit (data not
shown). This is in line with previously made observations
which describe no detectable IFN-  or IL-4 production of
separated CD4  or CD8  T cells after primary alloantige-
neic stimulation (42, 43).
These results clearly indicate, that LIGHT is essential for
efficient activation of cytotoxic T lymphocytes in an allo-
Figure 5. Delayed allogeneic skin graft rejection in LIGHT / CD28 /  mice. Groups of 4–9 mice were given tail skin transplants from fully alloge-
neic LIGHT /  (H-2d) mice. Grafts were monitored daily. Black circles, WT animals or mice heterozygous for either the cd28 or the light allele (n   9);
white circles, CD28 singly deficient mice, WT, or heterozygous for light (n   4); black triangles, LIGHT singly deficient mice, WT, or heterozygous for
cd28 (n   5); white triangles, LIGHT CD28 doubly deficient mice (n   5).1620 Phenotype of LIGHT-deficient Mice
geneic MLR in vitro. Interestingly, the accompanying de-
crease in cytokine production by LIGHT-deficient spleno-
cytes encompassed not only Th cell type 1 responses
represented by IFN-  and IL-2 but also the typical Th cell
type 2 cytokines IL-4 and IL-10. Detailed analyses revealed
that LIGHT has direct influence on the proliferative activ-
ity of CD8  T cells and the IL-2 production of the CD4 
T cell subset.
Discussion
The biological functions of the individual members of
the TNF ligand and receptor families are highly complex
and span from developmental processes to innate and adap-
tive immune responses (1, 29, 44). Insight into the under-
lying molecular mechanisms was gained by gene targeting
or administration of receptor Fc-fusion proteins. However,
when receptors are engaged by several distinct ligands, as is
the case for HVEM and LT R (4, 45), or if ligands bind to
more than one receptor, as is the case for LIGHT (4, 16),
only gene targeting can reveal the individual developmen-
tal and immunological roles of a defined molecule. In this
study, LIGHT was inactivated in the germline of the
mouse. We demonstrate that the recently described TNF/
LT core family member LIGHT is implicated in the co-
stimulatory activation of T cells and, in cooperation with
LT , in formation of MLNs.
Secondary lymphoid organs including peripheral and
MLNs, spleen, and PP are present with a properly devel-
oped and functional intact microarchitecture in LIGHT
singly deficient animals, suggesting that in the absence of
LIGHT-sufficient signaling activity through the LT R is
provided by the LT 1 2 heterotrimer. However, one can
still not completely exclude a possibly additional role of
HVEM signaling in lymphoid organogenesis since LT 3-
HVEM interactions are intact in LIGHT-deficient animals.
Figure 6. Impaired CTL responses and cytokine production after allogeneic MLR activation. (A) Splenocytes from LIGHT /  (black symbols) or
LIGHT /  (white symbols) H-2b mice were cultured with irradiated LIGHT /  or LIGHT /  H-2d splenocytes. On day 5, CTL activity of effector
splenocytes was assessed against the H-2d target P815 (circles) or the H-2b target EL-4 (triangles) in a standard 51[Cr]-release assay. One representative of
five independent experiments is shown. (B) On day 5, cytokine amounts in the supernatant of the MLR were measured by sandwich ELISA.   d.l.: be-
low detection limit. Two representatives of five independent experiments are shown. (C) FACS® analysis was performed on allogeneic MLRs on days 0,
4, and 5. Shown is the ratio of CD8  versus CD4  cells in MLRs with LIGHT /  or LIGHT /  (black circles) or LIGHT /  (white circles). Each circle
represents an independent MLR. Means of experimental groups are shown as bars. Asterisk indicates statistically significant results (P   0.0025).
Figure 7. Proliferation and IL-2 production of
CD4- or CD8-depleted LIGHT /  splenocytes af-
ter allogeneic MLR activation. Splenocytes from
LIGHT /  (black bars) or LIGHT /  (white bars) H-2b
mice were either depleted for CD4  or CD8  cells,
followed by coculture with irradiated LIGHT /  or
LIGHT /  H-2d splenocytes, respectively. (A) For the
measurement of proliferation in the absence of CD4 
or CD8  cells, 3[H]-thymidine was added for the last
9 h of a 4-d culture period. One representative of three
independent experiments is shown. Please note that di-
rect  -counting was used. (B) Amounts of IL-2 on day
5 in the supernatant of MLRs. Cytokine concentra-
tions were measured by ELISA. One representative of
two independent experiments is shown. *P   0.007;
**P   0.002.1621 Scheu et al.
Next, the putatively redundant roles of LIGHT and
LT 1 2 heterotrimers were addressed by intercrossing
LIGHT /  and LT  /  mice. Our studies with LIGHT / 
LT  /  mice revealed a cooperative role for LIGHT
with LT  in MLN development. Generally, LT  singly
deficient animals retain MLNs, with frequencies of LT -
deficient animals containing MLNs ranging from 100 to
60% in different laboratories (27, 28, 46, 47). The basis of
the differences reported in frequency of MLNs in LT 
strains is not clear but might relate to influences of back-
ground or housing conditions. Compared with these data
and to our own LIGHT / LT  /  littermates, animals
doubly deficient for LIGHT and LT  exhibited a mark-
edly reduced frequency of mice containing MLNs, in-
dicating that in the absence of LT , LIGHT provides
alternative signaling via the LT R, the latter being in-
dispensable for MLN development (24). The presence of
MLNs in 25% of the LIGHT/LT  doubly deficient ani-
mals hints at a yet undiscovered ligand signaling via LT R
or a weak binding activity of the LT 3 homotrimer to the
LT R in vivo, though in vitro data do not support the lat-
ter possibility (45).
The relatively conserved splenic microarchitecture of
LT  single knockout mice lacking LT 1 2 heterotrimers
with largely intact T and B cell segregation is retained in
LIGHT/LT  double knockout animals which contrasts to
the more disturbed situation found in LT R- as well as
LT -deficient mice (24–26). Thus, LIGHT does not seem
to contribute to the organization of the splenic microenvi-
ronment, suggesting again a yet unknown third ligand for
the LT R. Alternatively, one can argue for a functional
role of LT  beside its interaction with the LT R as mem-
ber of the LT 1 2 heterotrimer. The three members of the
TNFR family described to engage LT  as homotrimer are
TNFRp55, TNFRp75, and HVEM. Since LT /TNF
doubly deficient animals have profound defects in T and B
cell segregation (46), the TNFRp55 and the TNFRp75
cannot be excluded from participating in splenic T and B
cell segregation. The role of HVEM in lymphoid organo-
genesis, however, has still to be elucidated. To this aim
HVEM deficient animals are currently being generated in
our lab.
Previous studies focused on LIGHT as a costimulatory
molecule involved in T cell proliferative responses and cy-
tokine secretion (8, 30, 37, 48). However, LIGHT / 
splenocytes responded normally to ConA-mediated ac-
tivation, thereby questioning conclusions drawn from
experiments where LT R-Fc or HVEM-Fc efficiently
blocked ConA induced proliferation of WT splenocytes
(37, 48). These discrepancies are explainable either by the
existence of an undiscovered alternative ligand for LT R
involved in T cell activation directly via HVEM or by re-
dundant functional roles of LT 3, blocked by HVEM-
Fc, or of LT 1 2, blocked by LT R-Fc. In contrast,
LIGHT /  T cells and LIGHT /  total splenocytes
showed a reduction in 3[H]-thymidine incorporation after
anti-CD3 stimulation yet normal cell cycle activity in both
CD4  and CD8  T cell subpopulations as measured in a
CFSE assay, a situation quite similar to the one found in
CD27 /  mice (49). The amount of incorporated 3[H]-
thymidine is influenced by the number of cell divisions as
well as the number of cells partaking in the cell cycle ac-
tivity, with the latter being also affected by the cell sur-
vival. Thus, one can assume an involvement of LIGHT in
T cell survival after TCR triggering.
Ex vivo CTL responses even to low infection doses of
VSV are unaffected in the absence of LIGHT. This is prob-
ably due to the ability of other accessory molecules as for
example CD28 (50) to provide sufficient costimulation in a
cytolytic or humoral immune response to VSV, masking a
possible involvement of LIGHT. Preliminary experiments
using LIGHT/CD28 doubly deficient animals, however,
show an almost complete lack of VSV-specific CTL activ-
ity, whereas the CD28 /  littermate controls retain a cer-
tain degree of lytic activity (data not shown).
CD28 as well as e.g., 4–1BB signaling alone have been
shown to be dispensable for allograft rejection (40, 41).
Lack of both CD28 and 4–1BBL leads to a delay of al-
lograft rejection of up to 14 d. In our studies, combined
deficiency for LIGHT and CD28 resulted in an allograft
survival time of up to 19 d. This observation most likely re-
flects the early requirement of LIGHT-HVEM signaling
during T cell activation in the course of which other co-
stimulatory molecules as e.g., 4–1BB/4–1BBL, CD40/
CD154, CD27/CD70, and OX40/OX40L (13, 29, 51) are
upregulated and then able to substitute for the missing
LIGHT-HVEM or LIGHT-LT R interactions.
To further elucidate the underlying mechanisms, addi-
tional in vitro studies were performed. Strikingly, LIGHT
was shown to be indispensable for mounting an effective
allogeneic CTL response in vitro. The basis for this lies in
the reduced frequency of activated CD8  T cells observed
in the allogeneic MLR. In addition, cytokines reduced in
the supernatant of MLRs from LIGHT-deficient spleno-
cytes included both Th cell type 1 and 2 cytokines contra-
dicting earlier observations that blockade of LIGHT co-
stimulation predominantly decreases Th1 cytokines (30).
By analyzing MLR responses after CD4  or CD8  T cell
depletion it could be demonstrated that the reduced fre-
quency of activated CD8  T cells was caused by a signifi-
cantly lower proliferation of the LIGHT /  CD8  T cells,
whereas proliferative responses of CD4  T cells appeared
not be affected by the absence of LIGHT. Additionally,
LIGHT is essential for sufficient IL-2 production by CD4 
T cells in an allogeneic MLR.
The more dramatic defects found in the absence of
LIGHT in allogeneic immune responses in vitro as com-
pared with in vivo might be explained by the virtual ab-
sence of tissue resident DCs as professional APCs in the
splenocyte preparations used for in vitro MLRs. Thus, the
generation of primary CTLs under these conditions could
be more dependent on the presence of LIGHT produced
by T cells as compared with in vivo situations after alloge-
neic skin transplantation or VSV infection, where fully ac-
tivated professional APCs expressing various costimulatory
molecules could substitute for a single LIGHT deficiency.1622 Phenotype of LIGHT-deficient Mice
In the future, crossing the LIGHT deficiency into MHC
class I– or II–restricted TCR transgenic backgrounds
should allow for a detailed analysis of the contribution of
LIGHT-mediated costimulation for either the CD4  or
CD8  T cell subpopulations. Interestingly, chronically in-
creased expression of LIGHT results in autoimmune disor-
ders (37, 48, 52).
Recent observations illuminate that the absence of
LIGHT leads to defects in DC maturation (12). This may
in turn result in decreased allogeneic CTL activity and de-
layed skin graft rejection. However, bone marrow–derived
DCs from LIGHT-deficient mice, maturated in the pres-
ence of CpG, LPS, or poly I:C, show unimpaired upregu-
lation of surface MHC class II, CD40, B7–1, and B7–2 as
well as intracellular IL-12 and TNF-  production (data not
shown). The expression patterns of both, LIGHT and
HVEM, suggest that ligand and receptor may function dur-
ing the earlier stages of the adaptive immune response, to
initially enforce or bias T cell activation before CD28 as
well as other costimulatory molecules take over. In conclu-
sion, our findings define a contribution of LIGHT in the
organogenesis of secondary lymphoid tissues and an impor-
tant involvement in the costimulation of T cell–mediated
immune responses, identifying LIGHT as a target molecule
in transplantation, vaccination, or cancer therapy.
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